DMD and Duchenne muscular dystrophy: In the present study, we evaluated a combined therapy approach in a DMD mouse model, by adding treatment of the anti-cholesterol drug simvastatin with the restoration of dystrophin expression by the intravenous delivery of an AAV-microdystrophin.